Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
SYNGENE Stock Analysis
Views
Red Flags
Positive
High and stable operating margin
Low Debt to Equity, not much change from last year
Company's earnings are of high quality
Consistently pays dividend
Company is net cash
Negative
Expensive and at a premium to industry median P/E
Analysts have been downgrading forward EPS estimates
Low revenue growth and in line with median growth of industry
Low EPS growth and lower than median growth of industry
Low dividend yield
Neutral
Moderate and stable ROE
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
SYNGENE Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
SYNGENE Bulk, Block & Insider Trades
SYNGENE Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Bonus
Bonus(1 new shares for 1 existing shares) Ex-date: 11th Jun 2019 Announced on: 24th Apr 2019
Company Profile
Syngene International Limited is an India-based integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors. The Companys services include discovery, development, manuf... Read More
Key personnel
Dr. Kiran Mazumdar ShawD
Non-Executive Chairman of the Board
Mr. Peter James Jonathan BainsD
Chief Executive Officer, Managing Director, Additional Director
Mr. Deepak Jain
Chief Financial Officer
Mr. Andrew Webster
Chief Human Resources Officer
Dr. Kenneth Barr
Senior Vice President - Research Services
Mr. Alex Del Priore
Senior Vice President - Manufacturing Services
Mr. Gaurav Kushwaha
Chief Technology Officer
Dr. Jayashree Aiyar
Chief Scientific Officer
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Syngene International Ltd.?
The current share price of Syngene International Ltd. is ₹ 627.08 as of 09 Jan 2026.
What is the PE ratio of Syngene International Ltd.?
The Price-to-Earnings (PE) ratio of Syngene International Ltd. is 53.81 as of the latest financial data.
What is the ROE and ROCE of Syngene International Ltd.?
Syngene International Ltd. has a Return on Equity (ROE) of 10.26% and a Return on Capital Employed (ROCE) of 11.79% as per the latest financial reports.
What is the market cap of Syngene International Ltd.?
The market capitalization of Syngene International Ltd. stands at ₹ 25,194.10 Cr.
What is the dividend yield of Syngene International Ltd.?
The dividend yield of Syngene International Ltd. is 0.20% based on the current market price.
What is the RSI of Syngene International Ltd.?
The Relative Strength Index (RSI) of Syngene International Ltd. is 37.47.
What is the FII and DII holding in Syngene International Ltd.?
Foreign Institutional Investors (FII) hold 16.31% and Domestic Institutional Investors (DII) hold 24.45% of Syngene International Ltd. shares.
What sector does Syngene International Ltd. belong to?
Syngene International Ltd. operates in the Healthcare sector.
What is the beta of Syngene International Ltd. stock?
The beta of Syngene International Ltd. stock is 0.97, indicating its volatility relative to the broader market.
